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Abstract 
Background: The EQ-5D instrument is arguably the most well-known and commonly used generic measure of 
health status internationally. Although the instrument has been employed in outcomes studies of diabetes mellitus in 
many countries, it has not yet been used in Nigeria.
Objective: This study was carried out to assess the sensitivity of the EQ-5D instrument in a sample of Nigerian 
patients with type 2 diabetes mellitus (T2DM).
Methods: A cross-sectional study was conducted using the EQ-5D instrument to assess the self-reported quality 
of life of patients with T2DM attending two tertiary healthcare facilities in south eastern Nigeria consenting patients 
completed the questionnaire while waiting to see a doctor. A priori hypotheses were examined using multiple regres-
sion analysis to model the relationship between the dependent variables (EQ VAS and EQ-5D Index) and hypoth-
esized independent variables.
Results: A total of 226 patients with T2DM participated in the study. The average age of participants was 57 years 
(standard deviation 10 years) and 61.1 % were male. The EQ VAS score and EQ-5D index averaged 66.19 (standard 
deviation 15.42) and 0.78 (standard deviation 0.21) respectively. Number of diabetic complications, number of co-
morbidities, patient’s age and being educated predicted EQ VAS score by −6.76, −6.15, −0.22, and 4.51 respectively. 
Also, number of diabetic complications, number of co-morbidities, patient’s age and being educated predicted EQ-5D 
index by −0.12, −0.07, −0.003, and 0.06 respectively..
Conclusion: Our findings indicate that the EQ-5D could adequately capture the burden of type 2 diabetes and 
related complications among Nigerian patients.
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Background
Type 2 diabetes mellitus (T2DM) is a complex and 
chronic disease that has a significant burden on both the 
patient and caregivers. A nationally-representative pop-
ulation-based survey among 13,591 Nigerians revealed a 
diabetes prevalence of 3.3 % [1]. The study also showed 
that almost half of the population with diabetes (48  %) 
were unaware about their condition. Furthermore, a 
higher prevalence of diabetes was associated with urban 
residence and overweight/obesity [1]. With the continu-
ing urbanisation and the increasing population in Nige-
ria, the incidence and burden of diabetes is expected to 
rise further.
The plethora of complications which diabetic patients 
have to face diminishes their health related quality of life 
(HRQoL). In addition to diabetes-related complications, 
episodes and fear of hypoglycaemia, as well as change in 
lifestyle could further lead to reduction in HRQoL. Thus, 
from the clinical point of view, HRQoL is an important 
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Instruments used in assessing HRQoL are generally 
grouped into preference-based and non-preference-
based measures [2]. Whereas preference-based measures 
assess the value which individuals place on symptoms 
or quality-of-life states, non-preference-based meas-
ures are primarily concerned with directly assessing the 
symptoms, disease progression, or quality of life [2]. 
The former combines quality and quantity of life and 
also incorporate the values that individuals place on 
particular states of health, thus allowing for estimation 
of quality-adjusted-life-years (QALYs) [2], a measure 
commonly used to summarise population health and 
in the economic evaluation of health interventions and 
technologies.
The EQ-5D-3L is arguably the most well-known and 
commonly used generic measure of health status interna-
tionally [3]. It is available in 169 languages and has been 
applied in numerous clinical, cost-effectiveness and pop-
ulation health studies. Of late, it is being used routinely 
by health-care systems to assess quality of life of patients 
[3]. Although the instrument has been employed in out-
comes studies of diabetes mellitus in many countries [4–
12], to our knowledge it has not yet been used in Nigeria. 
Therefore, the aim of this study was to assess the feasi-
bility of using the EQ-5D-3L in clinical practice and for 
clinical studies in Nigeria by measuring its sensitivity to 
disease intensity among Nigerian diabetic patients.
Methods
Study design
A cross-sectional study in which the EQ-5D-3L instru-
ment was used to assess the health related quality of 
life of a sample of patients with T2DM was conducted. 
The patients were recruited from two teaching hospitals 
in Anambra state, south east Nigeria, namely: Nnamdi 
Azikiwe University Teaching Hospital (NAUTH) and 
Anambra State University Teaching Hospital Amaku 
(ASUTH). Both hospitals are the only tertiary hospitals 
in Anambra State, which is one of 36 states in the south-
eastern part of Nigeria. Nnamdi Azikiwe University 
Teaching Hospital (NAUTH) is a 355 bed multi annex 
complex, providing both specialized and comprehen-
sive medical care services. ASUTH is also a government 
owned, newly upgraded tertiary health institution, with a 
200 bed capacity. Only patients diagnosed with diabetes 
on the ICD10-E11 i.e., T2DM, and who could read and 
understand English were included. Severely ill patients as 
well as those who were in hospital for a follow-up visit 
were included in the study.
Study instrument
The EQ-5D instrument, which is described more fully 
in a separate paper (13), is a standardised instrument 
for measuring health outcomes. The instrument pro-
vides a simple descriptive profile and a single index 
value for health status. It is primarily designed for self-
completion by respondents and is ideally suited for use 
in postal surveys, in clinics and for face-to-face inter-
views. It is cognitively simple, taking only a few minutes 
to complete. The instrument has five dimensions which 
are mobility; self-care; usual activities; pain/discomfort 
and anxiety/depression. Each dimension has three lev-
els (no problems, some problems, and major problems) 
which together define 243 health states (3 to the power of 
5 gives the 243 possible combinations). The instrument 
also has a number of country-specific scoring functions 
available, which allow for the determination of utilities 
specific to certain settings. The study adopted a time 
trade off (TTO) method of health utility measurement 
as applied in Zimbabwe [13], which is the only African 
country with country-specific scoring functions. The 
questionnaire covered the patients’ basic demographic 
details and clinical information and also included a gen-
eral health visual analogue scale (EQ VAS). Using a verti-
cal 20 cm graduated line, patients reported their current 
level of health state by placing a mark on the line. The 
scale is anchored with 0 to represent the worst imagina-
ble health state, and 100 to represent the best imaginable 
health state.
Data administration and collection
Researchers distributed the self-administered question-
naires to the patients while they were waiting to see a 
doctor in the diabetic clinic of the two tertiary hospitals. 
Where necessary, the researchers assisted the patients or 
clarified any queries about the questionnaire. The ques-
tionnaires were collected after the patients had com-
pleted them. The number of complications (as specified 
by ICD 10) and co-morbidites (none diabetes mellitus 
related illness) were afterwards retrieved from clini-
cal notes. The study was conducted between May and 
August 2014. At NAUTH, this was done on pre-set dia-
betic clinic days. ASUTH had no special diabetic clinic 
days and so the survey was conducted on random days.
Ethical clearance
This study was approved by the Ethics committee of 
Nnamdi Azikiwe University Teaching Hospital Nnewi, 
Nigeria. All procedures were carried out according to the 
study protocol approved by the Ethics Committee. Oral 
informed consent was obtained from each patient. The 
information about participants’ identity was not included 
with the other data and only the principal investiga-
tor had access to this information. No reference to the 
participant’s identity was made at any stage during data 
analysis.
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Statistical analysis
Health profiles were presented in frequencies strati-
fied by age group. EQ VAS score and EQ-5D index were 
presented as mean  ±  standard deviation. In order to 
establish construct validity, a priori hypotheses on their 
relevance in T2DM and their ability to test the perfor-
mance of the EQ VAS score and EQ-5D index were pos-
tulated. We hypothesized that (1) patients with more 
complications will have poor utility, (2) patients with 
more morbidity will have poor utility, (3) utility will 
decease with increasing age; and (4) gender will have no 
effect on the utility of T2DM. The dependent variables 
were EQ VAS score and EQ-5D index and both were 
characterised as continuous variables. Independent 
variables were age, gender, level of education, number 
of diabetic complications and number of co-morbidi-
ties. Age was characterised as continuous variable, gen-
der was treated as binary data while level of education, 
number of diabetic complication and number of co-
morbidities were treated as categorical data. Using the 
stepwise method, a multiple regression was conducted 
to examine if the hypothesized independent variables 
predicted EQ VAS and EQ-5D index. Data analysis was 
conducted with SPSS 14.0® (Chicago, Illinois, USA). All 
hypotheses tested were two-tailed, with significance set 
at p < 0.05.
Results
A total of 226 patients consented to complete the 
questionnaires used in the study. There were a greater 
number of male participants as compared to females. 
Majority of the participants (81  %) formal education 
compared to those without any formal education. 
There were more participants with diabetic complica-
tions and co-morbidities compared to those without 
complications and co-morbidity. Details of respond-
ents’ demographic and clinical data are shown in 
Table 1.
Results of multiple regression analysis showed that 
number of diabetic complications, number of co-mor-
bidities, patients age and being educated predicted EQ 
VAS score, [F (4, 221) = 33.14, p = < 0.01, R2 = 0.375]. In 
the same vein, number of diabetic complications, num-
ber of co-morbidities, patients age and being educated 
predicted EQ-5D index, [F (4, 221) = 43.43, p = < 0.01, 
R2 = 0.44]. Details of the multiple regression of EQ VAS 
score and EQ-5D with demographic and clinical variables 
are shown in Table 2.
Table  3 shows the health profile of the study popula-
tion stratified by age group. The percentage of patients 
with no problem was similar in all health dimensions 
(>60  %) except for pain/discomfort, where only 47  % of 
the patients indicated no pain or discomfort.
Discussion
This study assessed the health related quality of life of 
patients with T2DM using the EQ-5D instrument with 
the Zimbabwe value set, and predicted the relation-
ship between the dependent variables (EQ VAS and 
EQ-5D index) and hypothesized independent variable. 
The presence of diabetic complications, co-morbidities 
and increasing age were hypothesized to reduce health 
related quality of life measures (EQ VAS and EQ-5D 
index) decrease with, while gender was hypothesized to 
have no influence on EQ VAS and EQ-5D index.
Table 1 Demographic and clinical variables of study popu-
lation and their association with EQ VAS and EQ-5D index 
(N = 226)
Variable Frequency (%) or mean ± SD
Gender
 Male 138 (61.1 %)
 Female 88 (38.9 %)
Level of education
 No formal education 43 (19.0 %)
 Formal education 183 (81.0 %)
Number of diabetic complications
 None 112 (49.6 %)
 One 78 (34.5 %)
 More than one 36 (15.95)
Number of co-morbidities
 None 98 (43.4 %)
 One 93 (41.2 %)
 More than one 35 (15.25)
Average age of participants 57 ± 10
Average EQ VAS score of participants 66.19 ± 15.42
Average EQ-5D index of participants 0.78 ± 0.21
Table 2 Multiple regression of  EQ VAS score and  EQ-5D 
with demographic and clinical variables (N = 226)
a Dependent variable
β SE t p value
EQ VASa
 Constant 96.64 5.71 16.94 <0.01
 Number of diabetic complications −6.76 1.22 −5.55 <0.01
 Number of co-morbidities −6.15 1.27 −4.83 <0.01
 Age −0.22 0.09 −2.39 0.02
 Patient’s level of education 4.51 2.19 2.06 0.04
Equation-5D indexa
 Constant 1.25 0.08 16.71 <0.01
 Number of diabetic complications −0.12 0.02 −7.35 <0.01
 Number of co-morbidities −0.07 0.02 −4.43 <0.01
 Age −0.003 0.001 −2.92 <0.01
 Patient’s level of education 0.06 0.03 2.10 0.04
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Results of the multiple regression analyses proved 
the a priori hypothesis to be true. The presence of com-
plications and co-morbidities as well as increasing age 
resulted in a decrease of EQ VAS and EQ-5D indexes, 
while gender was not associated with either of the two 
indexes. Similar results have been shown in other stud-
ies. For instance, in their study, Clarke and colleagues 
observed that higher index scores of 0.1 derived from 
EQ-5D were associated with an additional 7 % lower risk 
of vascular events, a 13 % lower risk of complications and 
up to 14 % lower risk of all-cause mortality [5]. Another 
study in which symptom severity of diabetic peripheral 
neuropathy in people with diabetes was correlated with 
health-related utility revealed that the EQ-5D index fell 
from an average of 0.81 in those without symptoms to 
0.25 in those with severe symptoms [7]. In further stud-
ies, diabetic complications and co-morbidities have been 
shown to have a direct negative effect on HRQoL [12, 14].
In our study, the ED-5D instrument also showed an 
association between being educated and higher HRQoL 
(i.e., higher EQ VAS and EQ-5D index). Although no 
hypothesis on the association between levels of educa-
tion quality of life was set a priori, the observed finding is 
logical. Being educated is likely to lead to a better under-
standing of the disease state and medical interventions 
required in diabetes management, and thus to greater 
motivation to self-care and adherence to therapy. 
Moreover, educated people generally belong to higher 
socio-economic strata compared to their less educated 
counterparts and thus can afford better health care ser-
vices. All these factors can contribute to a higher quality 
of life. A study of adults conducted in Spain in which the 
SF-36 Health Survey was used showed similar findings. 
Perceived health status was observed to decline with 
decreasing education level, except in women with second 
level education who had a higher mean rating on various 
health dimensions than women with third level educa-
tion [15].
The findings of this study show that EQ-5D is a sensi-
tive instrument for measuring HRQoL outcomes of Nige-
rian diabetic patients. This is in line with a systematic 
review on the validity, reliability and responsiveness of the 
EQ-5D in T2DM studies, which indicated that the EQ-5D 
can adequately capture the burden of T2DM and related 
complications in patient subgroups [10]. We therefore 
postulate that the EQ-5D instrument could be suitable 
for various applications in Nigeria in relation to diabetic 
health. These applications may include among others 
the following: economic evaluations to inform decisions 
about adoption of new technologies for diabetes care by 
hospitals, populations health surveys to aid ‘needs based’ 
allocation of budgets, clinical and observation studies and 
routine use in hospital to assess providers’ performance.
Conclusion
The findings of this study indicate that the EQ-5D can 
adequately capture the burden of type 2 diabetes and 
related complications in most patient subgroups in 
Nigeria.
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